| Sofosbuvir: A novel treatment option for chronic hepatitis C infection HK Bhatia, H Singh, N Grewal, NK Natt Journal of pharmacology and pharmacotherapeutics 5 (4), 278-284, 2014 | 274 | 2014 |
| Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management H Singh, P Thangaraj, A Chakrabarti Journal of clinical and diagnostic research: JCDR 7 (11), 2602, 2013 | 112 | 2013 |
| Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies E Arora, H Singh, YK Gupta Journal of family medicine and primary care 5 (2), 248-253, 2016 | 90 | 2016 |
| Canagliflozin: A novel SGLT2 inhibitor for type 2 diabetes mellitus S Kaushal, H Singh, P Thangaraju, J Singh North American journal of medical sciences 6 (3), 107, 2014 | 60 | 2014 |
| Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease H Singh, N Grewal, E Arora, H Kumar, AK Kakkar Journal of Natural Science, Biology, and Medicine 7 (1), 4, 2016 | 44 | 2016 |
| Repurposing potential of ketamine: opportunities and challenges CS Gautam, SS Mahajan, J Sharma, H Singh, J Singh Indian journal of psychological medicine 42 (1), 22-29, 2020 | 30 | 2020 |
| Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges H Singh, AK Kakkar, P Chauhan Expert Review of Anti-Infective Therapy 18 (10), 997-1003, 2020 | 28 | 2020 |
| Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead H Singh, P Chauhan, AK Kakkar European Journal of Pharmacology 890, 173717, 2021 | 27 | 2021 |
| Knowledge and awareness of diabetes and diabetic ketoacidosis (DKA) among medical students in a tertiary teaching hospital: An observational study H Singh, P Thangaraju, S Kumar, U Aravindan, H Balasubramanian, ... Journal of clinical and diagnostic research: JCDR 8 (4), HC04, 2014 | 25 | 2014 |
| Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection SS Gautam, CS Gautam, VK Garg, H Singh Expert Review of Clinical Pharmacology 13 (11), 1183-1190, 2020 | 18 | 2020 |
| Old wines in new bottles: repurposing opportunities for Parkinson's disease AK Kakkar, H Singh, B Medhi European Journal of Pharmacology 830, 115-127, 2018 | 18 | 2018 |
| Bedaquiline: a new weapon against MDR and XDR-TB H Singh, NK Natt, N Garewal, T Pugazhenthan Int J Basic Clin Pharmacol 2 (2), 96-102, 2013 | 17 | 2013 |
| Decoding the roadmap for capacity building of pharmacology academicians in catering to drug information center services in a developing country P Kumar, A Patil, AK Kakkar, H Singh The Journal of Pharmacy Technology: jPT: Official Publication of the …, 2019 | 16 | 2019 |
| Lack of Awareness of Pharmacovigilance among Young Health‑care Professionals in India: An Issue Requiring Urgent Intervention GCS Singh Jagjit, Singh Harmanjit, Rohilla Ravi, Kumar Rajiv Int J App Basic Med Res 8 (3), 158-163, 2018 | 16 | 2018 |
| Hypersensitivity reaction with deferasirox A Sharma, E Arora, H Singh Journal of Pharmacology and Pharmacotherapeutics 6 (2), 105-106, 2015 | 16 | 2015 |
| Metformin: activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action S Goel, R Singh, V Singh, H Singh, P Kumari, H Chopra, R Sharma, ... Frontiers in Genetics 13, 1022739, 2022 | 14 | 2022 |
| The promise of dolutegravir: a novel second generation integrase strand transfer inhibitor H Singh, M Kaur, A K Kakkar, H Kumar Current Clinical Pharmacology 11 (2), 88-94, 2016 | 13 | 2016 |
| Evaluation of treatment satisfaction, efficacy and safety of dipeptidyl peptidase-4 inhibitors in geriatric patients with type 2 diabetes mellitus: A cross-sectionalcomparative … H Singh, A Chakrawarti, H Singh, P Guruprasad, YK Gupta Journal of Family Medicine and Primary Care 7 (1), 70-76, 2018 | 12 | 2018 |
| Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal … P Thangaraju, H Singh, A Chakrabarti Indian Journal of Cancer 52 (3), 257-260, 2015 | 10 | 2015 |
| Sleep-walking a rarest side effect of zolpidem H Singh, P Thangaraju, NK Natt Indian journal of psychological medicine 37 (1), 105-106, 2015 | 10 | 2015 |
Dr. Pugazhenthan Thangaraju MBBS,...All India Institute Of Medical Sciences,(AIIMS) RaipurVerified email at aiimsraipur.edu.in
